Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update – Nasdaq
|
Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update
Nasdaq “In 2016, we significantly broadened our scientific platform with CRISPR/Cpf1 and advanced forms of CRISPR/Cas9, demonstrated proof-of-editing in vivo for our most advanced program in LCA10, and expanded our leadership team with the addition of our … |
Yahoo Finance |
Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations
Yahoo Finance Some type 1 diabetes (T1D) patients can be cured from the disease, at least for a number of years, with a stem cell transplant — those were the results of a clinical trial monitored by City of Hope’s Bart Roep, Ph.D., the Chan Soon-Shiong Shapiro … |
Business Wire (press release) |
Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations
Business Wire (press release) DUARTE, Calif.–(BUSINESS WIRE)–Some type 1 diabetes (T1D) patients can be cured from the disease, at least for a number of years, with a stem cell transplant — those were the results of a clinical trial monitored by City of Hope’s Bart Roep, Ph.D … |